ARCHIVES

Investigation finds no evidence FDA’s Crawford had affair with subordinate.

This article is from The Cancer Letter archive.

Vol. 31 No. 23 | June 10, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Gerald Dodd, Walter Lawrence Head ACS; Reauthorization Bills Expected Early ‘91

November 16, 1990

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Malpractice Reform Bill Introduced

July 28, 1989

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Obituary: Paul Rogers, Former Congressman, Instrumental In National Cancer Act Passage.

October 17, 2008

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011